Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common neurodegenerative diseases that occur either in relatively rare, familial forms or in common, sporadic forms. The genetic defects underlying several monogenic familial forms of AD and PD have recently been identified, however, the causes of other AD and PD cases, particularly sporadic cases, remain unclear. To gain insights into the pathogenic mechanisms involved in AD and PD, we used a proteomic approach to identify proteins with altered expression levels and/or oxidative modifications in idiopathic AD and PD brains. Here, we report that the protein level of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), a neuronal de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial PD, is down-regulated in idiopathic PD as well as AD brains. By using a combination of two-dimensional gel electrophoresis and mass spectrometry, we have identified three human brain UCH-L1 isoforms, a full-length form and two amino-terminally truncated forms. Our proteomic analyses reveal that the full-length UCH-L1 is a major target of oxidative damage in AD and PD brains, which is extensively modified by carbonyl formation, methionine oxidation, and cysteine oxidation. Furthermore, immunohistochemical studies show that prominent UCH-L1 immunostaining is associated with neurofibrillary tangles and that the level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains. Together, these results provide evidence supporting a direct link between oxidative damage to the neuronal ubiquitination/de-ubiquitination machinery and the pathogenesis of sporadic AD and PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This dysfunction contributes to neuronal damage and death by several mechanisms, including ER stress and the accumulation of oxidatively damaged proteins, which in the normal brain are usually degraded by the UPS and autophagy to keep their levels low8,50,53,55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“a crucial part of the UPS is oxidatively damaged and dysfunctional in both aMCI and AD brain, namely, ubiquitin carboxyl-terminal hydrolase L-1 (UCH L1)34,55–57.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
In the citing paper
“the failure of oxidatively damaged UCH L1 to perform its function in aMCI and AD brains leads to accumulation of ubiquitinylated proteins, decreased proteasome function, and subsequent accumulation of damaged, aggregated proteins55.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [55]
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Roepstorff, P., & Fohlman, J. (1984) · Biological Mass Spectrometry · doi:10.1002/bms.1200111109 · Cited by 2,633
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Methionine residues as endogenous antioxidants in proteins
Levine, R. L., Mosoni, L., Berlett, B. S., & Stadtman, E. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15036 · Cited by 1,041
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Research works printed but not linked: 2
- Ischiropoulos, 2003, J. Clin. Invest., 111, 163, 10.1172/jci200317638 · DOI · Paper page
- Wu, 1996, Alzheimer's Res., 2, 163
Cited by
Items 301–400 of 571
Rogers, N. K., Paine, S., Bedford, L. E., & Layfield, R. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01063.x · Cited by 35
Yadav, S., Dixit, A., Agrawal, S., Singh, A. K., Srivastava, G., Singh, A. K., Srivastava, P. K., Prakash, O., & Singh, M. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8291-8 · Cited by 34
“Many proteins that include, α-synuclein andUCHL-1, are dysregulated in patients and are expected to help in understanding and solving a few mysteries of PD pathogenesis [146, 147].”
BackgroundNakamura, T., Oh, C.-K., Zhang, X., Tannenbaum, S. R., & Lipton, S. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0081 · Cited by 33
Serial protein labeling with infrared maleimide dyes to identify cysteine modifications
Riederer, I. M., Moreno-Herero, R., Leuba, G., & Riederer, B. M. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.04.006 · Cited by 39
Xilouri, M., Kyratzi, E., Pitychoutis, P. M., Papadopoulou-Daifoti, Z., Perier, C., Vila, M., Maniati, M., Ulusoy, A., Kirik, D., Park, D. S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr521 · Cited by 34
“Providing a further link to neurodegeneration, UCH-L1 is down-regulated and/or inactivated through oxidation in the brains of PD and Alzheimer’s disease (AD) patients (24,25).”
Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson’s Disease
Бунеева, О. А., & Medvedev, A. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021303 · Cited by 32
“UCHL1 from PD brains was characterized by increased (up to 10-fold) levels of oxidized UCHL1 [130].”
BackgroundInfluentialCircular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets
Vakili, O., Asili, P., Babaei, Z., Mirahmad, M., Keshavarzmotamed, A., Asemi, Z., & Mafi, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220829164211 · Cited by 36
Retrotransposon-associated long non-coding RNAs in mice and men
Ganesh, S., & Svoboda, P. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1818-5 · Cited by 33
“and Alzheimer’s disease [9, 55].”
Neuroproteomics as a promising tool in Parkinson’s disease research
Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 33
Wu, Y., Chen, C., Chen, Y.-C., Chao, C., Ro, L. S., Fung, H., Hsiao, Y.-C., Hu, F.-J., & Lee‐Chen, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.013 · Cited by 32
“Reduced UCHL1 protein expression has been reported in PD [10].”
BackgroundHashimoto, M., Tozawa, R., Katakura, M., Shahdat, H., Haque, A. M., Tanabe, Y., Gamoh, S., & Shido, O. (2011) · Food & Function · doi:10.1039/c1fo00002k · Cited by 32
Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease
Gaamouch, F. E., Liu, K., Lin, H., Wu, C., & Wang, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105046 · Cited by 34
Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.036 · Cited by 31
UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein
Xie, M., Han, Y., Yu, Q., Wang, X., Wang, S., & Liao, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150032 · Cited by 31
“These results are consistent with the previous reports that impaired or deficient ubiquitin hydrolytic activity of UCH-L1 is capable of affecting the degradation and turnover of proteins [11, 13].”
InfluentialProteomics of vitamin B12 processing
Hannibal, L., DiBello, P. M., & Jacobsen, D. W. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0568 · Cited by 31
Control of Deneddylation by the COP9 Signalosome
Schmaler, T., & Dubiel, W. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_5 · Cited by 31
Contu, V. R., Kotake, Y., Toyama, T., Okuda, K., Miyara, M., Sakamoto, S., Samizo, S., Sanoh, S., Kumagai, Y., & Ohta, S. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12762 · Cited by 31
“Down-regulated as well as oxidatively modified UCH-L1 have been detected in the brains of patients with idiopathic PD (Choi et al. 2004).”
BackgroundInhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues
Mostert, S., Mentz, W., Petzer, A., Bergh, J. J., & Petzer, J. P. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.005 · Cited by 32
“128 Section 3: Mass spectra...................................................................................................... 144 Acknowledgements.................................................................................................................. 147 i LIST OF ABBREVIATIONS AND ACRONYMS A ADH Aldehyd…”
BackgroundInfluentialThe Proteomics of Neurodegeneration
Johnson, M. D., Yu, L., Conrads, T. P., Kinoshita, Y., Uo, T., McBee, J. K., Veenstra, T. D., & Morrison, R. S. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505040-00006 · Cited by 32
Proteomic Approaches to Study Cysteine Oxidation: Applications in Neurodegenerative Diseases
Pham, T. K., Buczek, W. A., Mead, R. J., Shaw, P. J., & Collins, M. O. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.678837 · Cited by 35
“In an early Oxi-Cys proteomics study, Choi et al. (2004) applied a 2-”
MethodLiu, H., Li, W., Rose, M. E., Hickey, R. W., Chen, J., Uechi, G. T., Balasubramani, M., Day, B. W., Patel, K. V., & Graham, S. H. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.323 · Cited by 32
Bergemalm, D., Forsberg, K., Jonsson, P. A., Graffmo, K. S., Brännström, T., Andersen, P. M., Antti, H., & Marklund, S. L. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900046-mcp200 · Cited by 31
“tissue in Alzheimer and Parkinson disease (30).”
Local proteins associated with methamphetamine‐induced nigrostriatal dopaminergic neurotoxicity
Liao, P., Kuo, Y., Hsu, H., Cherng, C. G., & Yu, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03346.x · Cited by 30
“Interestingly, a recent study reported that the protein level of ubiquitin C-terminal hydrolase L1/PGP 9.5 was down-regulated in idiopathic PD and Alzheimer’s disease (Choi et al. 2004).”
BackgroundInfluentialUCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma
Morris, M. C., Bercz, A., Niziolek, G. M., Kassam, F., Veile, R. A., Friend, L. A., Pritts, T. A., Makley, A. T., & Goodman, M. D. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.06.023 · Cited by 29
Balakrishnan, R., Jannat, K., & Choi, D. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103105 · Cited by 32
“In addition, postmortem studies have revealed that age-dependent increases in oxidative damage and mitochondrial dysfunction may contribute to increased oxidative stress in AD [34 – 36].”
BackgroundThe regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes
Zhang, H., Sun, Y., Hu, R., Luo, W., Mao, X., Zhao, Z., Chen, Q., & Zhang, Z. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.03.018 · Cited by 29
The ubiquitin C‐terminal hydrolase UCH‐L1 regulates B‐cell proliferation and integrin activation
Rolén, U., Freda, E., Xie, J., Pfirrmann, T., Frisan, T., & Masucci, M. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00501.x · Cited by 29
“In addition, UCH-L1 activity is also regulated by other post-translational modifications, such as O-glycosylation [49] and oxidation that appear to be a major cause of UCH-L1 inactivation in the brain of Alzheimer’s and Parkinson’s disease patients [50].”
BackgroundYing, Z., Wang, H., & Wang, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180013 · Cited by 31
“The first report showing its linkage to neurodegeneration was the identification of the relationship between the I93M mutation of UCHL1 and familial PD [58].”
BackgroundHuang, Q., & Huang, H. (2011) · PROTEOMICS · doi:10.1002/pmic.201100084 · Cited by 28
“Dysfunction of UCHL1 can lead to an accumulation of a-synuclein and neurofibrillary tangles, which links to Parkinson’s disease and Alzheimer’s disease, respectively [48, 49].”
BackgroundGuo, Y., Lu, Y., Zheng, Y., Chen, X., Dong, J., Yuan, R.-R., Huang, S., Yu, H., Wang, Y., Chen, Z.-Y., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3148-16.2017 · Cited by 30
“Decreased UCH-L1 expression has been observed in the brains of AD mice and AD patients (Choi et al., 2004; Poon et al., 2013) and the overexpression of UCH-L1 reduces the number of A plaques and improves memory deficits in AD mice (Gong et al., 2006; Zhang et al., 2014).”
BackgroundThe Emerging Role of lncRNAs in Spinal Cord Injury
Wang, F., Liu, J., Wang, X., Chen, J., Kong, Q., Ye, B., & Li, Z. (2019) · BioMed Research International · doi:10.1155/2019/3467121 · Cited by 29
“Previous studies have found that the mutations of the UCHL1 gene and oxidative inactivation of the Uchl1 protein were associated with familial PD [27].”
ResultResearch Progress of DUB Enzyme in Hepatocellular Carcinoma
Zhao, J., Guo, J., Wang, Y., Ma, Q., Shi, Y., Cheng, F., Lu, Q., Fu, W., Ouyang, G., Zhang, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920287 · Cited by 33
Proteome analysis of the sera from Chinese Parkinson's disease patients
Zhao, X. S., Xiao, W., Pu, X., & Zhong, L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.063 · Cited by 27
The Expression and Significance of Neuronal Iconic Proteins in Podocytes
Sun, Y., Zhang, H., Hu, R., Sun, J., Mao, X., Zhao, Z., Chen, Q., & Zhang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093999 · Cited by 27
Chen, J., Huang, R. Y. ‐., & Turko, I. V. (2013) · Analytical Chemistry · doi:10.1021/ac400831z · Cited by 27
Yan, C., Huo, H., Yang, C., Zhang, T., Chu, Y., & Liu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.140 · Cited by 28
Oxidative Damage in Parkinson's Disease
Sherer, T., & Greenamyre, J. T. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.627 · Cited by 27
Sjödin, S., Hansson, O., Öhrfelt, A., Brinkmalm, G., Zetterberg, H., Brinkmalm, A., & Blennow, K. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700100 · Cited by 29
Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Shi, H., & Zhao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020831 · Cited by 28
“Here, we summarize their effects on the mechanisms involved in tau aggregation and degradation.”
BackgroundKinumi, T., Shimomae, Y., Arakawa, R., Tatsu, Y., Shigeri, Y., Yumoto, N., & Niki, E. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.973 · Cited by 27
Modelling the Role of UCH-L1 on Protein Aggregation in Age-Related Neurodegeneration
Proctor, C. J., Tangeman, P. J., & Ardley, H. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013175 · Cited by 27
“For example, the level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains [9].”
BackgroundUbiquitin C-Terminal Hydrolase L1 regulates myoblast proliferation and differentiation
Gao, H., Hartnett, S., & Li, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.027 · Cited by 26
“In the brain of patients with Parkinson’s and Alzheimer’s disease (AD), UCHL1 protein level were reduced[9].”
BackgroundLatina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
“…2 December 2018 | Volume 12 | Article 487 a neuron-specific ubiquitin C-terminal hydrolase involved in disease pathogenesis (Pasinetti, 2001; Choi et al., 2004; Gong et al., 2006) which is enriched at nerve terminals (Liu et al., 2002) where it controls their physiopathological structural…”
BackgroundNg, A. S. L., Tan, Y. J., Lu, Z., Ng, E. Y., Ng, S. Y., Chia, N. S. Y., Setiawan, F., Xu, Z., Keong, N. C. H., Tay, K. Y., et al. (2020) · Aging · doi:10.18632/aging.102695 · Cited by 26
UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo
Mitra, S., Epshtein, Y., Sammani, S., Quijada, H., Chen, W., Bandela, M., Desai, A. A., Garcia, J. G. N., & Jacobson, J. R. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00492.2020 · Cited by 26
Caudle, W. M., Pan, S., Shi, M. Y., Quinn, T. J., Hoekstra, J. G., Beyer, R. P., Montine, T. J., & Zhang, J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800043 · Cited by 27
“Two recent proteomic studies also demonstrated the oxidative modification and altered expression of DJ-1 and UCHL-1 in PD brains [56, 57].”
BackgroundWulfänger, J., Biehl, K., Tetzner, A., Wild, P. J., Ikenberg, K., Meyer, S., & Seliger, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28278 · Cited by 25
Jeong, A., Auger, S. A., Maity, S., Fredriksen, K., Zhong, R., Li, L., & Distefano, M. D. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00486 · Cited by 26
Self-citationA systems biology approach for studying neurodegenerative diseases
Lam, S. C. C., Bayraktar, A., Zhang, C., Türkez, H., Nielsen, J., Borén, J., Shoaie, S., Uhlén, M., & Mardinoğlu, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.010 · Cited by 28
Spiechowicz, M., Bernstein, H., Dobrowolny, H., Leśniak, W., Mawrin, C., Bogerts, B., Kuźnicki, J., & Filipek, A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.009 · Cited by 25
Frisan, T., Coppotelli, G., Dryselius, R., & Masucci, M. G. (2012) · The FASEB Journal · doi:10.1096/fj.12-211946 · Cited by 26
“In addition, the activity of UCH-L1 is affected by post-translational modifications, such as O-glycosylation (26); oxidation (27), which appears to be a major cause of UCH-L1 inactivation in the brain of patients with Alzheimer and Parkinson diseases; and farnesylation, which promotes the association of UCH-L1 with ce…”
BackgroundRole of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Nielsen, P. Y., Okarmus, J., & Meyer, M. (2023) · Cells · doi:10.3390/cells12040651 · Cited by 25
Wang, Q., Zhao, X., He, S., Liu, Y., An, M., & Ji, J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0023-8 · Cited by 24
Identification of a novel chemical potentiator and inhibitors of UCH-L1 by in silico drug screening
Mitsui, T., Hirayama, K., Aoki, S., Nishikawa, K., Uchida, K., Matsumoto, T., Kabuta, T., & Wada, K. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.016 · Cited by 24
“In the brains of patients with sporadic Parkinson’s disease, UCH-L1 is down-regulated and oxidatively modified (Choi et al., 2004).”
Shevchenko, G., Wetterhall, M., Bergquist, J., Höglund, K., Andersson, L. I., & Kultima, K. (2012) · Journal of Proteome Research · doi:10.1021/pr300808h · Cited by 26
Anjo, S. I., He, Z., Hussain, Z., Farooq, A., McIntyre, A., Laughton, C. A., Carvalho, A. N., & Finelli, M. J. (2024) · Antioxidants · doi:10.3390/antiox13060681 · Cited by 29
“Carbonylation has been previously observed on carboxyl-terminal hydrolase L1 (UCH-L1), a deubiquitinating enzyme that can be mutated in familial forms of early-onset PD [93].”
BackgroundThe Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity
Wu, M., Su, H., & Zhao, M. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00332-2 · Cited by 24
Chen, Y., Wang, W., Fu, X., Sun, Y., Lv, S., Liu, L., Zhou, P., Zhang, K., Meng, J., Zhang, H., et al. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122858 · Cited by 23
A putative role for lncRNAs in epigenetic regulation of memory
Irwin, A. B., Bahabry, R., & Lubin, F. D. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105184 · Cited by 25
Park, J., Tucci, A., Cipriani, V., Demidov, G., Rocca, C., Senderek, J., Butryn, M., Velić, A., Lam, T., Galanaki, E., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.07.006 · Cited by 25
Pfeffer, M., Plenzig, S., Gispert, S., Wada, K., Korf, H., & von Gall, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.019 · Cited by 24
“In this study, we demnstrated that a mutation in UCH-L1, an enzyme which is ownregulated in idiopathic AD and PD (Choi et al., 2004), as an impact on circadian locomotor activity rhythms and ffects brain regions involved in the control of the sleep- Data are expressed as the mean SEM of six animals…”
BackgroundInfluentialGene expression profiling of mesenteric lymph nodes from sheep with natural scrapie
Filali, H., Martín‐Burriel, I., Harders, F., Varona, L., Hedman, C., Mediano, D. R., Monzón, M., Bossers, A., Badiola, J. J., & Bolea, R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-59 · Cited by 23
“UCHL1 is abundantly expressed in nervous system tissues [51], and gene variants and changes in the activity of UCHL1 have been associated with neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases [27,52-55].”
BackgroundSultana, R., & Butterfield, D. A. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780024 · Cited by 24
Khetani, S., Kollath, V. O., Eastick, E., Debert, C. T., Sen, A., Karan, K., & Sanati‐Nezhad, A. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111715 · Cited by 23
Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
Advani, D., Gupta, R. V., Tripathi, R. S., Sharma, S., Ambasta, R. K., & Kumar, P. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104841 · Cited by 25
Puri, S., & Hsu, S. D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166879 · Cited by 24
Nakamura, T., Gu, Z., & Lipton, S. A. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00284.x · Cited by 24
“In addition to the quality control of proteins provided by molecular chaperones, the ubiquitin-proteasome system (UPS) is involved in the clearance of abnormal or aberrant Correspondence Stuart A. Lipton, Center for Neuroscience and Aging, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla…”
BackgroundInfluentialThe Ubiquitinated Axon: Local Control of Axon Development and Function by Ubiquitin
Pinto, M. J., Tomé, D., & Almeida, R. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-20.2021 · Cited by 23
“, 2006), and post-translational modifications (Choi et al., 2004; Z. Liu et al., 2009) in UCH-L1 have been linked to Alzheimer’s and Parkinson’s disease, thus further reinforcing that the inability to maintain steady-state levels of neuronal ubiquitin is likely to underlie emergence of neurologic defects.”
BackgroundInfluentialLi, Z., Du, X., Wen, L., Yu, L., Qin, J., Chen, Z., Huang, Y., Wu, X., Luo, H., Lin, Y., et al. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100948 · Cited by 27
Specific Changes of Serum Proteins in Parkinson's Disease Patients
Lu, W., Wan, X., Liu, B., Rong, X., Zhu, L., Li, P., Li, J., Wang, L., Cui, L., & Wang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095684 · Cited by 24
Oxidation Proteomics: The Role of Thiol Modifications
Riederer, B. M. (2009) · Current Proteomics · doi:10.2174/157016409787847448 · Cited by 25
Kang, J., Liu, M., Yang, Q., Dang, X., Li, Q., Wang, T., Qiu, B., Zhang, Y., Guo, X., Li, X., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1558078 · Cited by 22
Current Understanding of Protein Aggregation in Neurodegenerative Diseases
Hu, C., Lin, M., Wang, C., & Zhang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110568 · Cited by 26
Liu, X., Huang, S., Wang, X., Tang, B., Li, W., & Mao, Z. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1542-8 · Cited by 23
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 22
Yu, Y., Pang, D., Li, C., Gu, X., Chen, Y., Ou, R., Wei, Q., & Shang, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02789-4 · Cited by 21
Reichelt, J., Sachs, W., Froembling, S., Fehlert, J., Studencka‐Turski, M., Betz, A., Loreth, D., Blume, L., Witt, S., Pohl, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37836-8 · Cited by 25
The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling
Feng, Z., Tao, S., Huang, Z., Zheng, B., Kong, X., Xiang, Y., Zhang, Q., Song, H., Xu, Z., Wei, X., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82152 · Cited by 21
“Ubiquitin C-terminal hydrolase 1 (UCHL1), enriched in neuronal tissues, is a deubiquitinating enzyme (DUB) responsible for protein turnover [8, 9].”
BackgroundDing, L.-L., Chu, W., Xia, Y., Ming, S., Li, T., Zhou, F., & Deng, D. Y. B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06003-8 · Cited by 22
Giuliano, S., Agresta, A. M., Palma, A. D., Viglio, S., Mauri, P., Fumagalli, M., Iadarola, P., Montalbetti, L., Salvini, R., & Bardoni, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110073 · Cited by 23
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Licker, V., & Burkhard, P. R. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.08.001 · Cited by 22
Aberrantly regulated proteins in frontotemporal dementia
Schweitzer, K. S., Decker, E. D., Zhu, L., Miller, R. E., Mirra, S. S., Spina, S., Ghetti, B. F., Wang, M., & Murrell, J. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.113 · Cited by 21
Maver, A., & Peterlin, B. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr313 · Cited by 23
Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore
Hernández-García, C., Rodríguez-Rodríguez, A., & Egea-Guerrero, J. J. (2015) · Brain Injury · doi:10.3109/02699052.2015.1079733 · Cited by 21
“The partial deficiency of UCH-L1 catalytic activity is related to CNS degenerative diseases such as Alzheimer and Parkinson disease and appears to have a gene expression pattern [70].”
BackgroundThe fine-tuning of proteolytic pathways in Alzheimer’s disease
Cecarini, V., Bonfili, L., Cuccioloni, M., Mozzicafreddo, M., Angeletti, M., Keller, J. N., & Eleuteri, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2238-6 · Cited by 21
“pathogenesis of AD [125–127].”
Alzheimer's disease: are blood and brain markers related? A systematic review
Khan, A. T., Dobson, R., Sattlecker, M., & Kiddle, S. J. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.313 · Cited by 22
“UCHL1 is a deubiquinating enzyme and over-expression has been shown to delay AD progression in vivo,(51) although low levels have been reported in postmortem brain tissue from AD patients.(52) CNPase plays a role in the synthesis and maintenance of myelin membranes with decreased levels reported in AD.”
BackgroundUCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment
Yu, Q., Zhang, H., Li, Y., Liu, C., Wang, S., & Liao, X. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0558-7 · Cited by 28
Paciotti, S., Wojdała, A. L., Bellomo, G., Toja, A., Chipi, E., Piersma, S. R., Pham, T. V., Gaetani, L., Jiménez, C. R., Parnetti, L., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01269-8 · Cited by 20
Thảo, Đ. T. P., An, P. N. T., Yamaguchi, M., & LinhThuoc, T. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1404-x · Cited by 20
“human UCH-L1 is also related to other neurodegenerative diseases, including Alzheimer’s disease (Choi et al. 2004) and Huntington’s disease (Xu et al.”
BackgroundHuman Ran Cysteine 112 Oxidation by Pervanadate Regulates Its Binding to Keratins
Tao, G., Zhou, Q., Strnad, P., Salemi, M., Lee, Y. M., & Omary, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412505200 · Cited by 19
Marshall, A. G., Watson, J. A., Hallengren, J. J., Walters, B. J., Dobrunz, L. E., Francillon, L., Wilson, J. A., Phillips, S. E., & Wilson, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084042 · Cited by 22
Polymorphism of HD and UCHL-1 genes in Huntington’s disease
Xu, E., Tang, Y., Li, D., & Jia, J. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.027 · Cited by 19
Kim, D., Paik, J. H., Shin, D.-W., Kim, H., Park, C., & Kang, J.-H. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.352 · Cited by 22
“Indeed, increased levels of oxidatively modified proteins and nitrated proteins have been identified in the SN of PD patients compared to controls [22-24], while a reduction of mitochondrial complex I activity, glutathione content [25] and ATP synthase expression [26] in the post-mortem brain of PD patients was observ…”
BackgroundParkinson's disease: animal models
Betarbet, R. S., & Greenamyre, J. T. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83011-9 · Cited by 20
“In sporadic PD, as recently reported, UCH-L1 is downregulated and oxidized in cerebral cortex (Choi et al., 2004).”
BackgroundBlockage of UCHL1 activity attenuates cardiac remodeling in spontaneously hypertensive rats
Han, X., Zhang, Y., Fu, T., Li, P., Cong, T., & Li, H. (2020) · Hypertension Research · doi:10.1038/s41440-020-0486-1 · Cited by 18
Nagamine, S., Kabuta, T., Furuta, A., Yamamoto, K., Takahashi, A., & Wada, K. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.015 · Cited by 18
Henderson, M. J., Vij, N., & Zeitlin, P. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044057 · Cited by 17
Mendsaikhan, A., Tooyama, I., Serrano, G. E., Beach, T. G., & Walker, D. G. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab056 · Cited by 17
“However, alternative hypotheses, including defects in lysosomal auto-phagic and ubiquitin proteasome degradation systems, have also been suggested and identified in AD brains (12, 13).”
BackgroundOxidation and ubiquitination in neurodegeneration
Riederer, B. M., Leuba, G., & ElHajj, Z. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213488484 · Cited by 19
“It was found oxidized in AD brain and its soluble levels were inversely proportional to the number of neurofibrillary tangles (NFTs).(30,45) These reports all point to an important role of the UPS in neurodegenerative diseases and suggest that protein alteration due to oxidation or to the lack of protein repair may st…”
BackgroundHeat shock proteins and their role in human diseases
Tóth, M. E., Gombos, I., & Sántha, M. (2015) · SZTE Publicatio Repozitórium (University of Szeged) · Cited by 25
Metadata
- Authors
- Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Li, Lian
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 13
- Pages
- 13256-13264
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2169393803
- Cited by
- 568
- References
- 38
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 13 · 2023: 14 · 2022: 20 · 2021: 36 · 2020: 16 · 2019: 16 · 2018: 22 · 2017: 28 · 2016: 24 · 2015: 26 · 2014: 34 · 2013: 29 · 2012: 30
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG010130, AG-10130, AG021489, R01AG021489)
- National Cancer Institute (P30CA054174, CA-54174)
- National Institute of Neurological Disorders and Stroke (NS-047199, R01NS047199)
- National Institute of Environmental Health Sciences (ES-12068, U54ES012068)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- UCHL1, Parkinson's disease, Alzheimer's disease, protein oxidation, carbonylation, methionine oxidation, cysteine oxidation, deubiquitination, neurofibrillary tangles, protein downregulation, brain proteome
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Brain, Chromatography, High Pressure Liquid, Coloring Agents, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Molecular Sequence Data, Mutation, Oxygen, Parkinson Disease, Mass Spectrometry, Trypsin, Immunoblotting, Electrophoresis, Gel, Two-Dimensional, Down-Regulation, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Oxidative Stress, Protein Isoforms, Proteome, Ubiquitin Thiolesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.